PREDICT-PD, the largest cross-sectional Parkinson’s study in the UK, has migrated its participant-facing research operations to Mantal, strengthening its ability to collect high-quality data at scale.
Led by researchers at Queen Mary University London (WMUL), PREDICT-PD is pioneering the early detection of Parkinson’s disease by studying thousands of individuals over time. As the study continues to grow, the need for a secure, flexible, and user-friendly digital platform became essential.
Mantal provides PREDICT-PD with seamless tools for participant recruitment, consent, digital assessments, longitudinal follow-up, and secure data management—all accessible from any device.
By adopting Mantal, the PREDICT-PD team can now reach a broader and more diverse population across the UK, reducing logistical barriers and enabling faster, more efficient study operations. This transition marks a significant step in modernizing Parkinson’s research and supporting earlier detection strategies that could transform patient outcomes.
